Exclusive interview with Dr. Madhukar Pai, MD, PhD
Every year, the world observes World TB Day on March 24 to raise awareness of the continued tuberculosis epidemic, especially in the developing world, and efforts to fight it. March 24 is the date in 1882 when mycobacterium tuberculosis – the pathogenic bacteria which causes the disease – was discovered the Nobel Prize winning scientist Dr. Robert Koch.
We would like to get your views on the status of health in India.
These next few questions are on tuberculosis and related fields in India.
We would like to know about your work.
Prof Madhukar Pai, MD, PhD is a Canada Research Chair in Epidemiology & Global Health at McGill University, Montreal. He is the Director of McGill Global Health Programs, and Associate Director of the McGill International TB Centre.
Madhu Pai did his medical training and community medicine residency in Vellore, India. He completed his PhD in epidemiology at UC Berkeley, and a postdoctoral fellowship at the UCSF. Madhu serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the STAG-TB committee of WHO, Geneva; Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance, New York. He has previously served on the Coordinating Board of the Stop TB Partnership. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, eLife, PLoS ONE, International Journal of TB and Lung Disease, among others.
Madhu’s research is mainly focused on improving the diagnosis and treatment of tuberculosis, especially in high-burden countries like India and South Africa. His research is supported by grant funding from the Gates Foundation, Grand Challenges Canada, and Canadian Institutes of Health Research. He has more than 300 publications. He is recipient of the Union Scientific Prize, Chanchlani Global Health Research Award, and Haile T. Debas Prize. He is a member of the Royal Society of Canada.
Twitter handle: @paimadhu
Subscribe our newsletter to stay updated